Although our study was focused on ovarian cancer, FOXC2 has been shown to induce EMT and CSC differentiation in other aggressive malignancies [85], and EMT-facilitated CSC differentiation has been linked to VM in several cancer types [77,94]. Here, FOXC2 is linked to ovarian carcinoma.